Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

OMID FATEMI

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1326293143
CMS profile
743090
Location
VENTURA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$9,749.61

107 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $6,360.00 4
Food and Beverage $3,389.61 103

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 107 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

OMID FATEMI

NPI 1326293143 · CMS profile ID 743090

Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology

VENTURA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 107 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1326293143?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
OMID FATEMI, NPI 1326293143, CMS profile ID 743090. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 107 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1326293143?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). OMID FATEMI, NPI 1326293143, CMS profile ID 743090. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 107 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1326293143?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
OMID FATEMI, NPI 1326293143, CMS profile ID 743090, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 107 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1326293143?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

107 matching records · $9,749.61 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 107 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 107.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Edwards Lifesciences Corporation $8.2607/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777101 CMS
Edwards Lifesciences Corporation $175.8207/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777111 CMS
Inari Medical, Inc. $17.9207/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140089494 CMS
Novartis Pharmaceuticals Corporation $34.5107/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086843291 CMS
Medtronic, Inc. $4.6707/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119267848 CMS
Biosense Webster, Inc. $27.0407/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077664940 CMS
Edwards Lifesciences Corporation $8.7507/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777097 CMS
Medtronic, Inc. $9.1707/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119267844 CMS
Boston Scientific Corporation $2.9607/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722492 CMS
Biosense Webster, Inc. $135.6707/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077664854 CMS
Biosense Webster, Inc. $144.9707/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077664942 CMS
Medtronic, Inc. $5.1607/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119267846 CMS
Edwards Lifesciences Corporation $11.6207/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777091 CMS
Boston Scientific Corporation $10.5007/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722400 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $17.6507/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080677006 CMS
Novartis Pharmaceuticals Corporation $31.1507/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086843289 CMS
Edwards Lifesciences Corporation $9.3906/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777087 CMS
Edwards Lifesciences Corporation $99.0506/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777093 CMS
Edwards Lifesciences Corporation $11.3806/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777095 CMS
ZOLL Circulation Inc $106.5406/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1067523243 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $95.2806/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080677004 CMS
Boston Scientific Corporation $7.0805/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722504 CMS
Kiniksa Pharmaceuticals International, plc $26.2005/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154874418 CMS
VivaQuant Inc, dba Rhythm Express $10.8605/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154303733 CMS
Edwards Lifesciences Corporation $10.5005/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777083 CMS
Boston Scientific Corporation $12.9005/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722406 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $17.8005/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080677000 CMS
Edwards Lifesciences Corporation $166.2405/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777089 CMS
Edwards Lifesciences Corporation $1,590.0005/06/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777073 CMS
Abbott Laboratories $35.9105/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124990840 CMS
Edwards Lifesciences Corporation $9.5005/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777079 CMS
Boston Scientific Corporation $25.0904/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722412 CMS
Boston Scientific Corporation $7.5804/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722392 CMS
Edwards Lifesciences Corporation $149.9804/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777077 CMS
Kiniksa Pharmaceuticals International, plc $28.4904/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154874408 CMS
Edwards Lifesciences Corporation $1,590.0003/21/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777069 CMS
Edwards Lifesciences Corporation $22.0403/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777071 CMS
Boston Scientific Corporation $3.5003/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722494 CMS
Medtronic, Inc. $161.6003/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119267842 CMS
Edwards Lifesciences Corporation $1,590.0003/07/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777065 CMS
Edwards Lifesciences Corporation $17.2502/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138777075 CMS
Boston Scientific Corporation $7.0002/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722502 CMS
Novartis Pharmaceuticals Corporation $31.1502/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086843287 CMS
Boston Scientific Corporation $6.8902/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722500 CMS
Boston Scientific Corporation $7.1702/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722506 CMS
Boston Scientific Corporation $12.2002/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722404 CMS
Boston Scientific Corporation $2.5002/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722490 CMS
Medtronic, Inc. $10.2502/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119267840 CMS
Abbott Laboratories $15.8001/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124990838 CMS
Boston Scientific Corporation $9.1701/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092722396 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,268.26 71
PY2020 $1,093.16 45
PY2021 $2,724.74 97
PY2022 $7,537.58 139
PY2023 $13,298.00 139
PY2024 $9,749.61 107
PY2025 $28,607.48 148

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $294,817.85 15
PY2024 Principal investigator $463,717.03 19
PY2023 Principal investigator $287,483.21 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $21,338.00 12/19/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175181955
Principal investigator 1 Janssen Research & Development, LLC $9,754.00 12/12/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175181995
Principal investigator 1 Janssen Research & Development, LLC $13,392.00 11/19/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175181964
Principal investigator 1 Janssen Research & Development, LLC $24,240.00 11/07/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175181948
Principal investigator 1 Novartis Pharmaceuticals Corporation $28,929.85 10/27/2025 Non-covered Recipient Entity
CARDIOLOGY ASSOCIATES MEDICAL GROUP, INC
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1190302565
Principal investigator 1 Janssen Research & Development, LLC $20,556.00 09/19/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175182004
Principal investigator 1 Janssen Research & Development, LLC $21,080.00 08/25/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175181971
Principal investigator 1 Janssen Research & Development, LLC $3,574.00 07/23/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175182033
Principal investigator 1 Janssen Research & Development, LLC $13,422.00 06/23/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175181940
Principal investigator 1 Janssen Research & Development, LLC $17,924.00 06/20/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175182010
Principal investigator 1 Janssen Research & Development, LLC $15,378.00 05/21/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175181988
Principal investigator 1 Janssen Research & Development, LLC $25,194.00 04/23/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175181979
Principal investigator 1 Janssen Research & Development, LLC $24,173.00 03/21/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175182039
Principal investigator 1 Janssen Research & Development, LLC $24,536.00 02/19/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175182019
Principal investigator 1 Janssen Research & Development, LLC $31,327.00 01/22/2025 Non-covered Recipient Entity
Crdlgy Associates Medcl Group-Ventura
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175182026